EU-wide consensus on confidential commercial data in drug marketing applications
This article was originally published in SRA
Executive Summary
The European Medicines Agency has finalised a much-awaited guideline on what constitutes "commercially confidential information" and "personal data" in a drug marketing authorisation application1-3. Despite reservations by the pharmaceutical industry, non-clinical data (ie pre-clinical information) has not been categorised as commercially confidential, which means it can be made available to the public4.
You may also be interested in...
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.